about
Transfer of host-derived α synuclein to grafted dopaminergic neurons in ratα-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells.Disease-modifying therapeutic directions for Lewy-Body dementiasParallel manifestations of neuropathologies in the enteric and central nervous systemsGenetics of Parkinson's disease - a clinical perspectiveInflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivoStructures of segments of α-synuclein fused to maltose-binding protein suggest intermediate states during amyloid formationNucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's diseaseATP13A2/PARK9 regulates secretion of exosomes and α-synucleinUnlike twins: an NMR comparison of two α-synuclein polymorphs featuring different toxicityPathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic miceHeat shock proteins in neurodegenerative disorders and agingAnle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington's disease.Vagotomy and Parkinson disease: A Swedish register-based matched-cohort studyMolecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other synucleinopathiesTowards translational therapies for multiple system atrophyFunctional network disruption in the degenerative dementias.Cutting the vagal highway blocks one point of entry for prion-like alpha-synuclein.Lys-63-linked ubiquitination by E3 ubiquitin ligase Nedd4-1 facilitates endosomal sequestration of internalized α-synuclein.Genetics of dementia.Gut feelings about smoking and coffee in Parkinson's disease.Neocortex and allocortex respond differentially to cellular stress in vitro and aging in vivoAcceleration of α-synuclein aggregation by exosomes.Alpha-synuclein transfers from neurons to oligodendrocytes.The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies.Stem cell pathologies and neurological diseaseα-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases.Molecular chaperones in Parkinson's disease--present and futurepH-Driven Polymorphism of Insulin Amyloid-Like Fibrils.α-Synuclein pathology accumulates in sacral spinal visceral sensory pathways.Frontal cortex neuropathology in dementia pugilistica.Exploring the link between glucocerebrosidase mutations and parkinsonismActivation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders.Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder.Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy.α-Synuclein oligomers and clinical implications for Parkinson disease.Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy.Alpha-Synuclein Expression in Patients with Parkinson's Disease: A Clinician's Perspective.
P2860
Q24609782-2BCC8A80-5071-4D48-93AF-1D3F19FF60AFQ24633663-47F6AE96-CCAD-4354-BB33-E2C91A543EA7Q26782907-C8BDC0A1-AB5A-4D73-9FA1-2C0652FC0614Q26823182-E20B28C4-E5A6-4834-9FD8-F511EF428CC3Q27022109-7CD8B3AE-FBBF-49A1-9F06-346345DF94A9Q27022728-B27BAF80-36B3-4213-9AB7-63FE16ADAB55Q27300819-2B0A579A-5E0C-4ADA-A752-B8A723DBCA27Q27667412-04834E92-EAC2-4389-BFF4-683DAE4CE2CCQ28085513-AC53CD49-575F-4ED0-A0D0-C23476E0AF73Q28118666-7145D5C2-E192-4289-9F33-CD3F7D31E79CQ28540502-3A8ADAAA-85E4-46C8-8487-C5CF349C990AQ29620597-979EBF7C-F197-4D03-AD53-78420320C03FQ30414556-4886DF63-6023-4A81-A4A5-8AD2698E3C17Q30540027-95CD1C61-3562-4E78-964A-ECAB55ED7079Q33579030-894DFFEF-4A36-4BF5-9A89-21FDF6979A81Q33714613-E4577C4A-693F-4EA0-A1A4-B0DFD8E8B19DQ33715640-FC8FBB1F-67E7-43E1-A8C2-2B445F2BB3FFQ33797532-0FB2AF32-4C2C-4C81-871F-444CBE16306AQ33967680-58985D45-7FFF-4ABF-9903-DE3F9D406432Q34044570-2F4CECA9-76B5-4206-97B5-D6070E67CD91Q34073890-90139D2E-07C9-4D9B-A01F-3971DAAC7995Q34248849-944D83F5-3465-4E1E-993F-DC21C291DCDFQ34416404-EFADE708-C620-4564-A0E4-BC6227F80B8DQ34639246-7184BEA6-0429-4A35-9AD9-6796AD515063Q35048929-C8AD27C2-18FE-4C20-B985-1C2CD6B134A1Q35079415-702E96DC-E084-4910-845E-DFE90C64D835Q35427654-62902B67-EF4A-48B6-89AF-B665C267C062Q35626316-7C36EA19-C2D2-4E70-BF45-447E9262E7A1Q35658734-D2B114DF-2CA6-4F37-B54B-7FB920D5BF53Q35688796-1560A9C1-7B61-4624-9DF1-C894C80ECB88Q35757446-3D454D04-191D-4D4A-8025-64FE09EFC76DQ35779463-78127814-1F88-4934-9365-0B8B36006C99Q35886739-3C318FD9-D571-4DA2-831F-CE90CC0B8B15Q35955350-FFD0E379-368F-4A47-87A9-AED3153E418DQ36148314-49D30F76-4328-4653-85D5-FF4D3570F14AQ36300054-7130C99D-1718-4896-B6BE-4F264F1AE074Q36341144-B2EF2945-20B8-431B-A995-28AE63B63059Q36718306-8AC6C6F9-AE80-4794-A017-9E4F1931BD12Q36873680-BA528CD8-623D-4D57-B881-C66811D50994Q36976868-00F66773-0EEA-4B0B-B212-C83078173657
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Are synucleinopathies prion-like disorders?
@en
Are synucleinopathies prion-like disorders?
@nl
type
label
Are synucleinopathies prion-like disorders?
@en
Are synucleinopathies prion-like disorders?
@nl
prefLabel
Are synucleinopathies prion-like disorders?
@en
Are synucleinopathies prion-like disorders?
@nl
P2093
P1433
P1476
Are synucleinopathies prion-like disorders?
@en
P2093
Christian Hansen
Elodie Angot
Jennifer A Steiner
P304
P356
10.1016/S1474-4422(10)70213-1
P577
2010-09-16T00:00:00Z